The American Medical Association believes that the timely dissemination of clinical trial data for public accessibility, improved enforcement deadlines for sharing results from clinical research studies, and the expansion of clinical trial registration will improve clinical practice and policy, prevent unnecessary research duplication, and help to inform present and future research.  The AMA therefore supports the AllTrials initiative and its goal of open access to clinical trial data.